Patient ID A-849 Reg.

Date 26-08-2023
Patient Age 23 Years Gender FEMALE Receiving Date 26-08-2023
Date Of Report 27-08-2023

TEST NAME RESULT UNIT NORMAL RANGE

HAEMOGLOBIN gm/dl 11.0-14.0 gm/dl
(SLS Method)

TOTAL COUNT
Erythrocyte (RBC) 5.02 milli/cum.m 4.2 – 5.4
HDF Method
Leucocyte (WBC) 5,900 /cu.mm 4000 – 11000
Flowcytometry

DIFFERENTIAL COUNTS
NEUTROPHIL 47 % 40% -75%
LYMPHOCYTE % 21% - 40%
MONOCYTE 02 % 02% -10%
EOSINOPHILS 03 % 00% - 06%
BASOPHIL 00 % 00% - 02%
PLATELET COUNT 3.15 lac/c mm (1.5 – 4.1 Lac / c mm)
ESR 1ST HOUR 10 MM 1st hrs. 0 -15 mm/h
Wester gren
PCV( PACK CELLVOLUME) 43.40 % Male :- 37-53 %,
Female :- 33-51%
MCV 86.45 fl 83fl – 101fl
MCH 28.28 Pg 27pg - 32pg
MCHC 32.71 % 31.5% - 34.5%
RDW cv 13.60 % 11.5% - 14.5%
PERIPHERAL BLOOD SMEAR
RBC morphology - Normocytic Normochromic.
White blood cells – No Abnormal cell seen.
Platelets – Adequate.

TEST DONE BY 3 PART AUTOMATATED ANALYZER MINDRAY BC-20s

N.B:- All reference ranges are age and sex matched. Reference limits mentioned are in accordance with the literature
provided along with the kit.

Checked By
 Patient ID A-849 Reg. Date 26-08-2023
Patient Age 23 Years Gender FEMALE Receiving Date 26-08-2023
Date Of Report 27-08-2023

TEST NAME RESULT

MP (MALARIA PARASITE) NOT FOUND

ADVICE: In case of negative malaria parasite report but strong clinical suspicion, examination of 3 consecutive
Days blood samples, preferably at the time of rising of temperature or malarial antigen detection test is advised.

N.B:- All reference ranges are age and sex matched. Reference limits mentioned are in accordance with the literature
provided along with the kit.

Checked By
 Patient ID A-849 Reg. Date 26-08-2023
Patient Age 23 Years Gender FEMALE Receiving Date 26-08-2023
Date Of Report 27-08-2023

Dilution-> 1:20 1:40 1:80 1:160 1:320

S. typhi ‘O’ antigen + + + + +
S. typhi ‘H’ antigen + + + + -
S. Paratyphi ‘AH’ antigen + - - - -
S. Paratyphi ‘BH’ antigen + - - - -

(+) Agglutination. (-) Non - Agglutination.

Comments :-The organism Salmonella typhosa is responsible for causing enteric fever or typhoid fever ,
which is characterized generally by very high consistent fever , loss of appetite transitory bacteraemia
round or oval shaped ulcer on smooth peritoneal surface of peyer’s patches and salitary lymphoid follicle
of ileum etc. The organism possess “O” antigen on the cell wall and “H” antigen on it’s flegella against
which the host body produces immune specific antibodies , to counteract the effect of corresponding
antigens. On the other hand the paratyphoid fever caused by Salmonella paratyphi A or Salmonella
paratyphi B is characterized by milder course of disease . these organisms also possess somatic “O” and
flagellar antigen which is termed as A(H) and B(H) respectively. The others organisms of Salmonella
species like Salmonella typhimurium responsible for causing food poisoning or Arizona group causing
fetal infection do have similar antigenic properties.

N.B:- All reference ranges are age and sex matched. Reference limits mentioned are in accordance with the literature
provided along with the kit.

Checked By
 Patient ID A-849 Reg. Date 26-08-2023
Patient Age 23 Years Gender FEMALE Receiving Date 26-08-2023
Date Of Report 27-08-2023

TEST NAME RESULT NORMAL RANGE

DENGUE NS1 ANTIGEN ELISA Non-reactive:<9 OD RATIO,
Method : Microwell ELISA Immunoassay.
Weakly Reactive:9-11 OD RATIO,
Test done by-
(BeneSphera ELISA Microplate Reader E21) Reactive:>11 OD RATIO
Reagent: J. Mitra & Co. Pvt. Ltd.

INTERPRETATION NEGATIVE
Method: Elisa

NOTE: Dengue virus is a flavivirus found largely in areas of the tropic and Sub-tropic. There are four distinct but antigenically
related serotypes of dengue viruses, and transmission is by mosquito , prinicipally Aedes aegypti and Aedes albopictus.
The mosquito-borne dengue viruses (serotype 1-4 ) cause dengue fever,
A severe flu-like illness, The disease is prevent in third world tropical regions and spreading to sub-tropical developed
countries - including The United States. WHO estimates that 50-80 million cases of dengue fever occur worldwide each
year ,including a potentially deadly form of the disease called dengue haemorrhagic fever (DHF) and dengue shock
syndrome (DSS).Primary infection of dengue virus results in a self-limiting disease characterized by mild to high fever
lasting 3 to 7 days, severe headache with pain behind the eyes, muscle and joint pain, rash and vomiting. Secondary
infection is the more common form of the disease in many parts of Southeast Asia and South America. This from of the
disease is more serious and can result in DHF and DSS. The major clinical symptoms can include high fever, haemorrhagic
events, and circulatory failure, and the fatality rate can be as high as 40%.Early diagnosis of DSS is particularly importantans
patients may die within 12 to 24 hours if appropriate treatment is not administered.
Primary dengue virus infection is characterized by elevations in specific NS1 antigen levels 0 to 9 days after the onset of
symptoms; this generally persites up to 15 days. Earlier diagnosis of Dengue reduces risk of complication such as DHF or
DSS, especially in countries where dengue is endemic.

N.B:- All reference ranges are age and sex matched. Reference limits mentioned are in accordance with the literature
provided along with the kit.

Checked By